Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02242474Phase 4Unknown
Phase 4, randomised, open-label trial in rheumatoid arthritis (RA) (2 arms), sponsored by CHU de Québec-Université Laval. Primary endpoint: Surgical site infection at 1 year. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02242474.